Prenatal Exposure of Guinea Pigs to the Organophosphorus Pesticide Chlorpyrifos Disrupts the Structural and Functional Integrity of the Brain
Overview
Neurology
Toxicology
Authors
Affiliations
This study was designed to test the hypothesis that prenatal exposure of guinea pigs to the organophosphorus (OP) pesticide chlorpyrifos (CPF) disrupts the structural and functional integrity of the brain. Pregnant guinea pigs were injected with chlorpyrifos (25 mg/kg, s.c.) or vehicle (peanut oil) once per day for 10 consecutive days, starting approximately on the 50th day of gestation. Cognitive behavior of female offspring was examined starting at 40-45 post-natal days (PND) using the Morris water maze (MWM), and brain structural integrity was analyzed at PND 70 using magnetic resonance imaging (MRI) methods, including T2-weighted anatomical scans and diffusion kurtosis imaging (DKI). The offspring of exposed mothers had significantly decreased body weight and brain volume, particularly in the frontal regions of the brain including the striatum. Furthermore, the offspring demonstrated significant spatial learning deficits in MWM recall compared to the vehicle group. Diffusion measures revealed reduced white matter integrity within the striatum and amygdala that correlated with spatial learning performance. These findings reveal the lasting effect of prenatal exposure to CPF as well as the danger of mother to child transmission of CPF in the environment.
Conductive hearing loss does not affect spatial learning and memory in middle-aged guinea pigs.
Barry K, Jimena J, Tarawneh H, Johnsen W, Osmanbasic A, Rodger J Sci Rep. 2024; 14(1):31103.
PMID: 39730908 PMC: 11680780. DOI: 10.1038/s41598-024-82408-5.
Fowler C, Reuben A, Stapleton H, Hoffman K, Herkert N, Barakat L Environ Res. 2024; 263(Pt 1):119990.
PMID: 39304016 PMC: 11608154. DOI: 10.1016/j.envres.2024.119990.
Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.
Piras I, Gabriele S, Altieri L, Lombardi F, Sacco R, Lintas C Antioxidants (Basel). 2021; 10(2).
PMID: 33499329 PMC: 7912005. DOI: 10.3390/antiox10020164.
Todd S, Lumsden E, Aracava Y, Mamczarz J, Albuquerque E, Pereira E Neuropharmacology. 2020; 180:108271.
PMID: 32814088 PMC: 7655673. DOI: 10.1016/j.neuropharm.2020.108271.
van den Dries M, Lamballais S, El Marroun H, Pronk A, Spaan S, Ferguson K Environ Res. 2020; 191:110047.
PMID: 32805249 PMC: 7657967. DOI: 10.1016/j.envres.2020.110047.